Blood Pressure Medication Shortage Exposes Deeper Systemic Failures The UK's healthcare system has been exposed as fragile and vulnerable to supply chain disruptions after the government placed Ramipril, a life saving blood pressure medication taken by over 6 million people, under a "serious shortage protocol.
" The move, which limits prescriptions to just one month's supply until October 30, is a stark reminder of the critical issues plaguing the global healthcare supply chain.
The root cause of this shortage lies in the complex web of global trade and supply chain management, rather than in the medication itself.